GM1 Ganglioside Effects on Parkinson's Disease

NCT00037830 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

94

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: GM1 ganglioside
DRUG: Placebo

Sponsor

Thomas Jefferson University

Collaborators

[object Object]